About
Aims and scope
BMJ Leader is an international, peer-reviewed, online only, subscription based journal that publishes articles in the field of healthcare leadership. With a focus on original research and reviews, the journal is a place of discussion and debate for the many disciplines that make up leadership in the health services.
BMJ Leader is the official journal of the Faculty of Medical Leadership and Management.
Ownership
BMJ Leader is co-owned by BMJ and the RCP in association with the Faculty of Medical Leadership and Management.
Editorial Board
For information about BMJ Leader’s Editor Dr James Mountford and the editorial team, please refer to the Editorial Board page
Journal information
| Publication Model | Subscription; with hybrid open access option |
|---|---|
| Frequency | Quarterly |
| Launch Date | 2017 |
| Peer Review Model | Single blind; the names of reviewers are hidden from the author |
| Online ISSN | 2398-631X |
Journal statistics
| Acceptance Rate | 86% |
|---|---|
| Rejection Rate | 14% |
| Time from Submission to First Decision | 37 days |
| Time from Acceptance to Publication | 17 days |
Contact information
For all contact information please refer to the contact us page.
For Authors
Please refer to the Instructions for authors
Subscriptions
To advertise
Rights and permissions
Affiliations
The Faculty of Medical Leadership and Management is the UK professional home for medical leadership. Its primary objective is to raise the standard of patient care by improving medical leadership.
BMJ is a founding member of COPE (the Committee on Publication Ethics), which provides a forum for publishers and Editors of scientific journals to discuss issues relating to the integrity of the work submitted to or published in their journals.
The EQUATOR Network is an international initiative that seeks to improve the value of medical research literature by promoting transparent, accurate reporting of research studies. BMJ is a sponsor of its activities.
BMJ is a founding organisation of the AllTrials initiative, which calls for all past and present clinical trials to be registered and their results reported.